Independent Advisor Alliance’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.84K | Sell |
10,000
-1,356
| -12% | -$1.34K | ﹤0.01% | 887 |
|
|
2025
Q1 | $16.4K | Sell |
11,356
-2,644
| -19% | -$3.81K | ﹤0.01% | 805 |
|
|
2024
Q4 | $30.8K | Buy |
14,000
+1,000
| +8% | +$2.2K | ﹤0.01% | 1341 |
|
|
2024
Q3 | $21.5K | Hold |
13,000
| – | – | ﹤0.01% | 699 |
|
|
2024
Q2 | $28.9K | Buy |
13,000
+1,500
| +13% | +$3.33K | ﹤0.01% | 692 |
|
|
2024
Q1 | $30.8K | Buy |
11,500
+1,500
| +15% | +$4.02K | ﹤0.01% | 690 |
|
|
2023
Q4 | $29.9K | Hold |
10,000
| – | – | ﹤0.01% | 668 |
|
|
2023
Q3 | $9.8K | Hold |
10,000
| – | – | ﹤0.01% | 646 |
|
|
2023
Q2 | $13.9K | Hold |
10,000
| – | – | ﹤0.01% | 664 |
|
|
2023
Q1 | $15.9K | Sell |
10,000
-350
| -3% | -$557 | ﹤0.01% | 663 |
|
|
2022
Q4 | $64 | Buy |
10,350
+144
| +1% | +$1 | ﹤0.01% | 399 |
|
|
2022
Q3 | $68K | Sell |
10,206
-100
| -1% | -$666 | ﹤0.01% | 602 |
|
|
2022
Q2 | $66K | Buy |
10,306
+306
| +3% | +$1.96K | ﹤0.01% | 595 |
|
|
2022
Q1 | $46K | Hold |
10,000
| – | – | ﹤0.01% | 645 |
|
|
2021
Q4 | $50K | Sell |
10,000
-1,500
| -13% | -$7.5K | ﹤0.01% | 655 |
|
|
2021
Q3 | $139K | Buy |
+11,500
| New | +$139K | 0.01% | 600 |
|